ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 187,65
0,00%
Dow Jones
39 387,76
0,85%
DAX
18 686,60
1,07%
Brent Oil
84,235
0,34%
Bitcoin
62 782,32
-0,42%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Zosano Pharma Corporation (ZSAN)

  7. Zosano Pharma Corporation (ZSAN) Actualités

ZSAN

Zosano Pharma (ZSAN)

Zosano Pharma Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ZSAN
DateHeureSourceTitreSymboleSociété
19/07/202217h48Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:ZSANZosano Pharma Corporation
08/06/202201h39Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ZSANZosano Pharma Corporation
02/06/202214h36Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ZSANZosano Pharma Corporation
02/06/202214h00GlobeNewswire Inc.Zosano Pharma Files Voluntary Petition for Relief Under Chapter 11NASDAQ:ZSANZosano Pharma Corporation
13/05/202222h17Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ZSANZosano Pharma Corporation
13/05/202222h00GlobeNewswire Inc.Zosano Pharma Reports First Quarter 2022 Financial ResultsNASDAQ:ZSANZosano Pharma Corporation
29/04/202222h02Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:ZSANZosano Pharma Corporation
29/04/202222h00GlobeNewswire Inc.Zosano Pharma Provides Corporate UpdateNASDAQ:ZSANZosano Pharma Corporation
11/04/202214h00GlobeNewswire Inc.Zosano Pharma Announces Reverse Stock Split Effective TodayNASDAQ:ZSANZosano Pharma Corporation
01/04/202222h22Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ZSANZosano Pharma Corporation
22/03/202212h46TipRanksMaxim Group Thinks Zosano Pharma’s Stock is Going to RecoverNASDAQ:ZSANZosano Pharma Corporation
17/03/202221h05GlobeNewswire Inc.Zosano Pharma Reports Fourth Quarter and Fiscal Year 2021 Financial ResultsNASDAQ:ZSANZosano Pharma Corporation
14/02/202212h19Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:ZSANZosano Pharma Corporation
11/02/202223h31Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ZSANZosano Pharma Corporation
09/02/202223h16Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ZSANZosano Pharma Corporation
09/02/202203h55GlobeNewswire Inc.Zosano Pharma Announces Pricing of $15.4 Million Public Offering of Common Stock and WarrantsNASDAQ:ZSANZosano Pharma Corporation
08/02/202222h10GlobeNewswire Inc.Zosano Pharma Announces Proposed Public Offering of Common Stock and WarrantsNASDAQ:ZSANZosano Pharma Corporation
05/01/202218h01GlobeNewswire Inc.CORRECTION - Zosano Pharma Announces Publication of Clinical Data Demonstrating Comparable Immunogenicity of a Trivalent Influenza Vaccine Formulated on its Transdermal Microneedle System Versus an Intramuscular Injection of the Vaccine at a Higher DoseNASDAQ:ZSANZosano Pharma Corporation
05/01/202215h20GlobeNewswire Inc.Zosano Pharma Announces Publication of Clinical Data Demonstrating Comparable Immunogenicity of a Trivalent Influenza Vaccine Formulated on its Transdermal Microneedle System Versus an Intramuscular Injection of the Vaccine at a Higher DoseNASDAQ:ZSANZosano Pharma Corporation
13/12/202122h30GlobeNewswire Inc.Zosano Pharma Announces Changes to Board of Directors; Appoints Cross Functional Business Executive Elaine M. YangNASDAQ:ZSANZosano Pharma Corporation
30/11/202103h45GlobeNewswire Inc.Zosano Pharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ZSANZosano Pharma Corporation
17/11/202114h00GlobeNewswire Inc.Zosano Pharma Announces the Successful Formulation of a COVID-19 Vaccine Candidate on its Microneedle Patch SystemNASDAQ:ZSANZosano Pharma Corporation
10/11/202122h10GlobeNewswire Inc.Zosano Pharma Reports Third Quarter 2021 Financial ResultsNASDAQ:ZSANZosano Pharma Corporation
04/10/202114h00GlobeNewswire Inc.Zosano Pharma Granted Type C Meeting with FDA Regarding NDA Resubmission for M207 Following Preliminary Top-Line Pharmacokinetic Study ResultsNASDAQ:ZSANZosano Pharma Corporation
02/09/202122h30GlobeNewswire Inc.Zosano Pharma to Present at the H.C. Wainwright Virtual Global Investment ConferenceNASDAQ:ZSANZosano Pharma Corporation
10/08/202122h05GlobeNewswire Inc.Zosano Pharma Reports Second Quarter 2021 Financial ResultsNASDAQ:ZSANZosano Pharma Corporation
20/07/202114h30GlobeNewswire Inc.Zosano Pharma Announces Issuance of U.S. Patent for Method of Rapidly Achieving Therapeutic Levels with M207 for the Acute Tr...NASDAQ:ZSANZosano Pharma Corporation
15/07/202112h30Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ZSANZosano Pharma Corporation
02/07/202123h07Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:ZSANZosano Pharma Corporation
21/06/202122h09Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ZSANZosano Pharma Corporation
 Showing the most relevant articles for your search:NASDAQ:ZSAN

Dernières Valeurs Consultées

NYSE
KO
Coca Cola
NYSE
DIS
Walt Disney
EU
ACA
Credit Agricole
EU
VK
Vallourec
NYSE
MRK
Merck
EU
BN
Danone
EU
PX1
CAC 40
EU
CAP
Capgemini
EU
SGO
Cie de SaintGobain
COIN
BTCUSD
Bitcoin
EU
RNO
Renault
EU
AF
Air FranceKLM
SPI
SP500
S&P 500
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés